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Abstract
Background: Mammalian Delta-like 1 (Dlk-1) protein shares homology with Notch ligands but
lacks a critical receptor-binding domain. Thus it is unclear whether it is able to interact with Notch
in vivo. Unlike mammals, Drosophila have a single Notch receptor allowing a simple in vivo assay for
mammalian Dlk1 function.
Results: Here we show that membrane-bound DLK1 can regulate Notch leading to altered cellular
distribution of Notch itself and inhibiting expression of Notch target genes. The resulting adult
phenotypes are indicative of reduced Notch function and are enhanced by Notch  mutations,
confirming that DLK1 action is antagonistic. In addition, cells expressing an alternative Dlk1 isoform
exhibit alterations in cell size, functions previously not attributed to Notch suggesting that DLK1
might also act via an alternative target.
Conclusion: Our results demonstrate that DLK1 can regulate the Notch receptor despite its
atypical structure.
Background
The protein encoded by the mammalian Delta-like 1
(Dlk1) is related to members of the Notch-Delta family of
signalling molecules, but differs in several key respects
from other members of this family. Dlk1 produces multi-
ple alternatively spliced transcripts, giving rise to protein
isoforms which are either membrane-bound or proteolyt-
ically cleaved and secreted (Fig. 1; [1]). Dlk1 has evoked
considerable interest because in mammals it is a pater-
nally expressed imprinted gene that is epigenetically regu-
lated, and defective imprinting of Dlk1  results in
developmental abnormalities [2,3]. Furthermore, targeted
deletion of Dlk1 in mice results in growth retardation,
skeletal malformation and obesity [4] and transgenic mice
ectopically expressing ovine Dlk1 in some muscle fibres,
exhibit muscle fibre hypertrophy [5]. The developmental
mechanisms leading to these abnormalities are unknown
and in particular it is unclear the extent to which this pro-
tein has the capability of regulating Notch signalling in
vivo, because it lacks an essential extracellular DSL domain
common to all known Notch ligands.
Notch-ligands are transmembrane proteins that are char-
acterised by a series of EGF-repeats in their extracellular
domain, and an N-terminal domain, referred to as the
DSL domain (Fig. 1; [6-8]). The latter appears to be critical
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for the interactions between the ligands and the Notch
receptor [6,9]. Although DLK1 contains 6 EGF-repeats
that are closely related to those found in Delta and Ser-
rate/Jagged, and can bind to Notch EGF repeats in a yeast
two-hybrid assay [10], it lacks the N-terminal DSL-
domain which is required for receptor binding and activ-
ity of known ligands (Fig. 1); it also differs from character-
ised Notch ligands because its intracellular domain is
considerably shorter. Truncation of the intracellular
domain renders Drosophila or Xenopus Delta proteins inca-
pable of activating the receptor [11-13]. Both its lack of a
DSL-domain and its short intracellular domain suggest
therefore that DLK1 would not be able to function as a
Notch ligand. However, as an inverse correlation between
Dlk1 levels and Notch activity have been observed in cul-
tured cells, it is possible that DLK1 could be a receptor
antagonist [14].
The Notch pathway is highly conserved throughout the
animal kingdom and has been most extensively studied in
Drosophila  where it was first identified [7,15]. Unlike
mammals, which have 4 different Notch receptors, Dro-
sophila has a single receptor and provides a simple system
to test whether DLK1 has the capability to regulate Notch
in vivo and whether it acts positively or negatively. This
approach has successfully been used to investigate func-
tions of bone fide mammalian Delta ligands, two of
which were effective in activating Drosophila Notch [16].
We therefore generated transgenic flies that express Dlk1
isoforms under the control of the Gal4/UAS system [17]
and tested for phenotypes indicative of alterations in
Notch function.
Results and Discussion
Phenotypes from expressing Dlk1 in the Drosophila wing
Three different Dlk1 variants were constructed that mimic
the different isoforms detected in vivo: S-Dlk, a secreted
form produced by proteolytic cleavage in the extracellular
domain, M-Dlk, transmembrane tethered form that lacks
the cleavage site, SM-Dlk retains the cleavage site and thus
has the capacity to be both membrane tethered and
cleaved (Fig. 1). We used a series of different Gal4 driver
Structure of Dlk and the 3 isoforms Figure 1
Structure of Dlk and the 3 isoforms. A) Schematic representation of several members of the Delta-Serrate family of Notch 
ligands. Comparative structure is shown including the EGF-repeats, signal peptide, extracellular proteolytic cleavage domain 
and transmembrane domain found in all the ligands in addition to the DSL domain that is missing in mouse DLK1. B) Schematic 
representation of the three DLK1 isoforms expressed in Drosophila. The M construct produces the membrane-bound isoform 
of DLK1, which lacks a proteolytic cleavage site. The SM construct produces the full-length DLK1 containing the proteolytic 
cleavage domain and the S form is engineered to produce the isoform normally generated by proteolytic cleavage.BMC Developmental Biology 2008, 8:11 http://www.biomedcentral.com/1471-213X/8/11
Page 3 of 9
(page number not for citation purposes)
lines to express these proteins in the developing wing and
assessed the adults for phenotypes that would be indica-
tive of effects on Notch activity.
Notch activity is required at many different stages in wing/
notum development. Characteristic phenotypes of Notch
gain of function are wing over-growth, ectopic wing mar-
gin structures, loss of veins and bristle loss [18-21]. Phe-
notypes caused by Notch loss of function are notching of
the wing margin, vein thickening and bristle duplication/
tufting or bristle loss [22,23]. The apparently contradic-
tory effects on bristles occur because Notch is involved
both in the selection of the sensory organ precursor (SOP)
cells and in the fates within each bristle lineage [23].
Expression of Drosophila  ligands in the wing produces
characteristics of both Notch activation and inhibition.
The latter occurs in the cells expressing highest levels of
ligands, and is due to an autonomous inhibitory effect on
the receptor referred to as cis-inhibition [9,24]. Expression
of mammalian ligands in similar assays either resulted
primarily in Notch activation (Dll1 and Dll4) or had no
effect (Dll3), none had robust cis-inhibitory effects [16].
When DLK1 protein was expressed in the wing using sev-
eral different Gal4 drivers we detected phenotypes that
were consistent with a reduction in Notch activity, includ-
ing wing notching, vein thickening and bristle duplica-
tions (Fig. 2 and data not shown). In all cases M-Dlk
produced the strongest phenotypes, SM-Dlk resulted in
much milder phenotypes and the secreted isoform, S-Dlk,
had little or no effect. The latter may not be surprising
because Notch ligands appear to require ubiquitinylation
of the intracellular domain and coupling with endocytosis
to be active [25-27]. The secreted isoform would not
undergo the necessary modifications.
To further investigate the consequences of expressing Dlk1
we focussed on the ptc::Gal4 driver which is expressed in a
stripe in the central region of the wing and in the scutel-
lum (Fig. 2A,B). We used two approaches to vary the levels
of expression. We tested effects at 25°C and 30°C, the
higher temperature increasing the effectiveness of the
Gal4, and we compared phenotypes from one and two
copies of the transgenes. Expression from one copy of M-
Dlk at 25°C resulted in highly penetrant phenotypes of
wing notches and multiple sense-organs, indicative of
reduced Notch activity (Fig. 2E,F,M,N). Both defects were
strongly enhanced at 30°C. In contrast, minor defects of
occasional bristle duplications were produced using one
copy of SM-Dlk (data not shown). The bristle defects were
more penetrant with two copies of SM-Dlk and occasional
wings had mild-notching (Fig. 2N). These effects were
considerably enhanced at 30°C (Fig. 1D,N). Thus both M-
Dlk and SM-Dlk produce defects consistent with an antag-
onistic effect on Notch. The transgene producing the
membrane tethered M-Dlk has a much more potent effect.
In addition to the Notch-related defects, we also observed
effects on cell proliferation. In particular, expression of
SM-Dlk resulted in fewer cells in the domain of expression
(Fig. 2I,J and Table 1). Within the reduced domain the
individual cells were larger than normal. In contrast,
expression of the M-Dlk caused a slight increase in cell
number in the domain of expression (Fig 2F,N). Together
these data suggest that DLK1 affects cell growth or prolif-
eration, and that the different isoforms may have distinct
inputs on this process. Furthermore, although there is evi-
dence that Notch can influence cell proliferation in the
wing [28], effects on cell size were not seen in other exper-
iments where Notch activity was modulated by ptc::Gal4
(e.g. with dominant negative ligands or with Su(H)).
Thus, effects on cell size seen with SM-Dlk may be sugges-
tive of additional target(s) or may reveal a novel aspect of
Notch function.
Some Dlk1 expression phenotypes are enhanced by Notch 
mutations
To confirm that phenotypes produced by M-Dlk and SM-
Dlk are due to effects on Notch, we asked whether they
could be enhanced if the levels of Notch were reduced in
flies heterozygous for a loss-of-function Notch  allele
(N55e11). Heterozygosity for Notch alone produces mild
wing nicking, slight broadening of the veins at the tips
(deltas) and occasional duplication of the scutellar mac-
rochaetae (Fig. 2G and data not shown). Even taking into
account the effects of Notch mutation on the wing mar-
gin, the frequency and the extent of wing notching from
both M-Dlk and SM-Dlk was enhanced in N/+ females
(Fig. 2H,N). Furthermore, the effects of bristle duplication
were also significantly enhanced (Fig. 2I–N). Thus by two
different criteria, the phenotypes produced by DLK1 are
enhanced by reducing the amount of Notch protein
present, indicating that DLK1 is antagonising the activity
of the Drosophila Notch receptor.
Although most of the effects of Dlk1  expression are
enhanced by Notch mutations, the wings from Notch/+;
ptc::Gal4/UAS::SM-Dlk have a similar size and number of
cells in the domain of expression to those with wild-type
dose of Notch. This is consistent with the hypothesis that
the effects on cell size are independent of an action on
Notch raising the possibility that there is an additional
target of DLK1.
Effects of Dlk1 expression on Notch targets in the wing 
imaginal disk
If DLK1 is antagonising Notch activity we would expect to
see down-regulation of Notch target genes in the wing
imaginal disc. We examined effects of expressing M-DlkBMC Developmental Biology 2008, 8:11 http://www.biomedcentral.com/1471-213X/8/11
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Phenotypes caused by expression of Dlk1 resemble Notch loss-of-function and are enhanced by Notch mutations Figure 2
Phenotypes caused by expression of Dlk1 resemble Notch loss-of-function and are enhanced by Notch muta-
tions. (A) Diagram showing domain of Ptc::Gal4 expression (blue) in the wing, red arrows indicate regions scored for Table 1 
(m = margin). (B) Wild-type wing. (C-F) Wings expressing SM-Dlk (C,D; 2 copies of transgene) and M-Dlk (E,F; 1 copy of trans-
gene). (G,H) Heterozygous N55e11/+ wings, phenotypes of M-Dlk expression (H) are enhanced. (I,J) Effects of SM-Dlk at 25°C 
(I,I') and 30°C (J,J') on cell number and cell size, cell number is reduced by stronger expression, (I,J; fewer cells between L3/L4, 
red arrows) and cell size is increased (I'J'; evident from spacing of the trichome hairs, e.g. red lines). (K-M) Ectopic sensory bris-
tles (arrows, wild-type has 4 sensory bristles) in the scutellum of SM-expressing (K), and M-Dlk expressing flies (L,M). Ectopic 
bristles are enhanced when Notch levels are reduced (N55e11/+; M). (N) Graph summarising the phenotypes obtained with dif-
ferent combinations at 25°C. (SM-Dlk was present in 2 copies).
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and SM-Dlk on two Notch targets. Expression of the tran-
scription factor Cut at the wing margin (d/v boundary;
Fig. 3A) is dependent on the activity of the Notch and
Wingless pathways [29]. The cut regulatory sequences con-
tain binding sites for the DNA-binding protein Su(H) (the
intracellular transducer of Notch activity, homologous to
CBF1 in mammals) suggesting that it is a direct target of
Notch activation [30]. Cut expression was strongly inhib-
ited by expression of M-Dlk and subtly reduced by expres-
sion of SM-Dlk (Fig. 3B–D). In addition, occasionally
there was some ectopic Cut detected at the boundary of
M-Dlk expression in the ventral part of the wing (Fig.
3C,D). This suggests that M-Dlk may also have some acti-
vating potential but only in the ventral domain, where the
Fringe glycosyl-transferase is absent. In this respect Dlk-1
appears more similar in function to Serrate, which is only
able to activate Notch molecules that are not modified by
Fringe [31].
The second target used was the Enhancer of split mβ gene
(E(spl)mβ), which is expressed in response to Notch in a
more widespread pattern in the wing (Fig. 3E; [32,33]. We
have previously mapped the regulatory sequences of this
gene and shown that its expression is dependent on Notch
activity [32]. Using a reporter construct where the regula-
tory sequences drive expression of a heterologous protein,
Expression of Dlk1 inhibits Notch target genes and leads to ectopic sensory organ precursors Figure 3
Expression of Dlk1 inhibits Notch target genes and leads to ectopic sensory organ precursors. (A) Wild-type wing 
imaginal disc, Cut (red) is detected in a stripe along the d/v boundary. (B) Expression of SM-Dlk (green, arrows) leads to a 
slight reduction in Cut (red). (C,D) Expression of M-Dlk (green, arrows) inhibits Cut (red) expression. ptc::Gal4 is expressed in 
a slight gradient, barely detectable levels of DLK1 in the anterior of the domain are still sufficient to inhibit Cut. A few cells 
where Cut is induced ectopically are detected posterior to the DLK1 expression domain (arrowhead). D is a higher magnifica-
tion of C, note that the M-Dlk is seen at the membrane of the expressing cells. (E,F) E(spl)mβ::CD2 expression in wild-type (E) 
and M-Dlk expressing disc. Arrows in F indicate the domain of M-Dlk expression where E(spl)mβ::CD2 is inhibited. (G,H) 
Senseless expression in wild-type (G) and M-Dlk expressing disc. Senseless expression is inhibited at the d/v boundary (arrows; 
characteristic of loss of Notch activity) and is expanded in the ventral and dorsal radius (arrowheads) indicative of ectopic sen-
sory organ precursors.
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Table 1: Cell numbers (+/- s.d.) in two regions of wings from wild type flies and flies expressing Dlk isoforms.
Wild type SM 30°C SM 25°C N/+; SM 30°C N/+; SM 25°C M 25°C
Margin 32.44(+/- 1.59) 22.41(+/- 2.92) 31.58(+/- 2.09) Nicks Nicks Nicks
L3/L4 15.22(+/- .83) 10.13(+/- 1.09) 14.86(+/- 0.77) 11.88(+/- 0.88) 14.75(+/- 0.89 17.08(+/- 1.31)
N ≥ 12 flies per genotype. See Figure 2 for areas used for counting. Reducing the dosage of Notch (columns labelled N/+) does not influence cell 
numbers.BMC Developmental Biology 2008, 8:11 http://www.biomedcentral.com/1471-213X/8/11
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the membrane protein CD2 [34] we tested effects of Dlk1
expression. M-Dlk strongly down-regulated
E(spl)mβ::CD2 throughout the domain of misexpression
(Fig. 3F; occasionally this was accompanied by slight
upregulation at the boundary) SM-Dlk had weaker but
still significant inhibitory effects (data not shown). The
inhibition of both E(spl)mβ and cut expression confirms
that expression of Dlk1 is antagonising Notch activity. As
this inhibition occurs within the domain of ligand expres-
sion, it most likely represents cis-inhibition, i.e. effects on
the receptor in the same cell. However we cannot rule out
the possibility that there are slight non-autonomous
inhibitory effects with M-Dlk, as the epithelium often
becomes deformed around the domain of expression.
We also wanted to verify that the effects of Dlk1 on bristles
reflect a reduction in Notch activity, because some of the
adult phenotypes (most notably bristle loss) can also be
brought about by increased Notch activity. We therefore
looked at a marker of sensory-organ precursors, Senseless
[35]. If DLK1 is antagonising Notch activity we would
expect an increase the number of sensory organ precursors
in a given cluster. This is what was observed in the clusters
that will form the chordotonal sensory organs of the dor-
sal and ventral radius (Fig. 3G,H). Both M-Dlk and SM-
Dlk increase the number of Senseless-expressing precur-
sors in these clusters, with M-Dlk having the stronger
effect (Fig 3H and data not shown).
M-Dlk and SM-Dlk show different cellular locations and 
effects on Notch protein
The differing severity of the M-Dlk and SM-Dlk might in
part be due to the transgenes being expressed at different
levels. However, the fact that even increasing the dosage
and temperature failed to properly redress the difference,
and that the two proteins had distinct effects on prolifera-
tion suggested that there are intrinsic differences in the
behaviours of the proteins. To investigate these questions
we stained wing discs with an antibody that recognises
DLK1. This revealed a striking difference in the behaviour
of the two proteins. M-Dlk had a cortical/membrane dis-
tribution (Fig. 4B,B',C,C'), whereas SM-Dlk accumulated
at highest levels basally, although some membrane asso-
ciated protein was detectable (Fig. 4D,D",E,E").
Co-staining with anti-Notch antibody revealed that M-
Dlk strongly affects the distribution of the endogenous
Notch protein (Fig. 4A',B',C'). The levels of Notch are ele-
vated in M-Dlk expressing cells, and there is more protein
accumulating at or close to the membrane of these cells.
Both these effects suggest that M-Dlk has an action on
Notch that stabilises the protein. Notch distribution is
much less affected by SM-Dlk, despite the fact that this
isoform consistently accumulates to much higher levels
than M-Dlk (Fig. 4D'). Nevertheless in some cells we also
observed redistribution of Notch to co-localise with the
SM-Dlk (Fig. 4D',E'). We take this co-variance in Notch
localisation with the expressed Dlk isoforms to indicate
that they are able to interact, since this resembles the
effects seen with expression of known ligands with func-
tional DSL domains [9]. In contrast, in these previous
studies, ligands with a mutated DSL domain were not able
to influence Notch distribution [9].
Conclusion
Dlk1 can regulate Notch signalling despite its atypical 
structure
Our data indicate that DLK1 has the capability to regulate
Notch receptors in spite of the fact that it lacks an N-ter-
minal DSL domain. This in vivo functional demonstration
that DLK1 can affect Drosophila Notch signalling and is
consistent with yeast two-hybrid data showing interaction
of DLK1 with Notch1 EGF repeats [10]. That this interac-
tion has likely functional consequences in mammals in
vivo, is supported by evidence suggesting that DLK1 can
modulate levels of Notch signalling in adipogenic cells in
culture [14]. In our assay the effects of DLK1 appear to be
largely inhibitory. This is in contrast to the effects seen
when the typical mammalian Delta ligands Dll1, Dll3 and
Dll4 were expressed in flies [16]. In those experiments,
both DLL1 and DLL4 were able to activate Drosophila
Notch, and DLL3 had no effect. Neither DLL3 not the
other two ligands produced inhibitory effects similar to
those seen here with DLK1. Thus, these effects are likely to
reflect specific characteristics of DLK1 itself.
Notch ligands have the unusual characteristic that they
inhibit the Notch receptors present on the same cell, as
well as activating receptors on adjacent cells [24,36]. It is
the autonomous cis-inhibitory activity that we detect with
DLK1, with little or no evidence for activation. Further-
more, the effects are most profound when we use a mem-
brane-tethered form of DLK1 (M-Dlk). However, our
results with DLK1 do not a priori indicate that DLK1 acts
solely as an inhibitor at the membrane. The ability of lig-
ands to activate the Notch receptors is affected by glyco-
sylation [37] and it is possible that the glycosylation state
of the Drosophila Notch is incompatible with DLK1 acti-
vation. It is also possible that species-specific differences
in endocytosis, in interactions with adaptor proteins, or in
ligand specificities might also influence the outcome in
our experiments. Furthermore, mammalian cells have 4
Notch receptors, and while two of these (Notch 1 and
Notch 2) contain the same number of extracellular EGF
repeats as Drosophila Notch, the others (Notch 3 and 4)
have fewer and may have different interactions/ligand
pairings. Thus the outcome of DLK1 actions could differ
according to which specific Notch receptor or ligand-
receptor pairing is affected. Nevertheless our results do
show that DLK1 has the ability to regulate Notch signal-BMC Developmental Biology 2008, 8:11 http://www.biomedcentral.com/1471-213X/8/11
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Expression of Dlk1 alters the cellular distribution of Notch Figure 4
Expression of Dlk1 alters the cellular distribution of Notch. (A-C) M-Dlk (A,A" green, white) is present at the cortex/
membrane of expressing cells and results in stabilization of Notch (A,A', B,B', C,C' red, white) within the stripe of M-Dlk 
expression (yellow arrows/line). (B-B") Higher magnification, cell outlines with M-Dlk and Notch enrichment are visible (e.g. 
arrowhead). (C-C") X/Z section, co-enrichment of Notch and M-Dlk on apical and lateral regions of cells is seen (e.g. arrow-
head; note there is also non-specific accumulation of anti-Dlk staining along the surface of the specimen). (D-E) SM-Dlk (D, D"; 
E, E"; green, white) accumulates on the basal surface of the epithelium (e.g. arrow in E,E"), and at lower levels around the mem-
brane/cortical regions. Less stabilisation/accumulation of Notch is detected, but there is enrichment at the cortex of some SM-
Dlk expressing cells (e.g. arrowheads). (A'-E') Notch channels only, (A"-E") anti-Dlk channels only. Yellow arrows and lines 
indicate domain of ptc::Gal4 driven expression.
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ling particularly when membrane tethered; hence it is
likely to be an important factor acting on this pathway in
mammalian development.
During mammalian embryogenesis, Dlk1 is expressed in
many of the key lineages known to depend on Notch sig-
nalling for appropriate development, including somite
derivatives [38]. The relative expression of Dlk1 and the
more typical Notch ligands may therefore play an impor-
tant role in modulating the temporal and spatial control
of Notch signalling in these cells. Once the expression and
function of DLK1 in situ is better characterised, this may
shed light on which of the mammalian receptors is likely
to be a target of DLK1, what the functional relationships
between DLK1 and other Notch ligands are, and whether
DLK1 acts positively as well as antagonistically on Notch
receptors.
Methods
Dlk1 constructs and transgenic flies
Three constructs were generated, representing the pre-
dominant forms of Dlk1 that are generated by alternate
splicing and proteolysis. Genomic fragments were gener-
ated from BAC103N10 (Accession number AJ320506)
and combined with appropriate fragments from a full
length cDNA clone containing the Dlk1  open reading
frame (IMAGE 604466) but lacking the protease cleavage
domain. Open reading frames were ligated into pUAST for
injection into yellow white flies. The first construct con-
tained the largest open reading frame harbouring the
intracellular and proteolytic cleavage domains (SM-Dlk),
the second lacked the cleavage domain (M-Dlk), the third
contained only the extracellular domain, equivalent to the
secreted form of DLK1 after cleavage (S-Dlk). This was
generated from the M form by truncating 5' of the proteo-
lytic cleavage domain (via Sac I digestion), prior to clon-
ing into pUAST. All constructs were sequenced to confirm
accurate synthesis. Several independent lines were iso-
lated and 3 lines of each were selected for further analysis,
based on expression levels (antibody staining) and
strength of phenotypes. All lines for a given construct gave
qualitatively similar results. Homozygous stocks were pre-
pared containing insertions on chromosomes II and III
and these were combined for experiments with 2 copies of
the transgenes.
Fly stocks and analysis of Adult phenotypes
Except where otherwise stated fly stocks used are as
described [39]. Adult flies were stored in 100% ethanol
and selected parts were mounted in Euparol for photogra-
phy.
Immunofluorescence
Dissection of larvae and immunofluorescence were as
described previously [40] except that dissections were car-
ried out in PBS. Primary antibodies were rabbit anti-DLK1
[41]; mouse anti-Senseless [35]; mouse anti-Cut (1/20;
[42]); mouse anti-Notch (C17.9C6 1/20; [43]. The latter
two antibodies were obtained from Developmental Stud-
ies Hybridoma Bank. Secondary antibodies were from
Jackson Immnunological. Images were collected using a
Leica TCS-NT-UV scanning confocal microscope.
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